InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3046% below fair value
$0.77−0.03 (-3.25%)
Close on Nov 12, 2026Market cap $35.98MP/E –Yield –
InspireMD EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
InspireMD's EPS for the twelve months ending Sep 30, 2025 was -$0.40. For fiscal 2025 it was -$0.76. The highest annual figure on record is -$0.76 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.76 | – |
| FY2024 | Dec 31, 2024 | -$0.76 | – |
| FY2023 | Dec 31, 2023 | -$0.82 | – |
| FY2022 | Dec 31, 2022 | -$2.35 | – |
| FY2021 | Dec 31, 2021 | -$2.03 | – |
| FY2020 | Dec 31, 2020 | -$6.97 | – |
| FY2019 | Dec 31, 2019 | -$72.00 | – |
| FY2018 | Dec 31, 2018 | -$250.05 | – |
| FY2017 | Dec 31, 2017 | -$26235.00 | – |
| FY2016 | Dec 31, 2016 | -$155790.00 | – |
| FY2015 | Dec 31, 2015 | -$1466062.50 | – |
| FY2013 | Jun 30, 2013 | -$9121875.00 | – |
| FY2010 | Dec 31, 2010 | -$1837500.00 | – |
| FY2009 | Dec 31, 2009 | -$1575000.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.17 | -177.3% |
| Q1 FY2026 | Mar 31, 2026 | -$0.16 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.17 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.26 | – |
| Q1 FY2025 | Mar 31, 2025 | $0.22 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.19 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.16 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.22 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.21 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.15 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.24 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.53 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.60 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.58 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.59 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.57 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.53 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.53 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.46 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.53 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.96 | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.93 | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.42 | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.90 | – |
| Q2 FY2019 | Jun 30, 2019 | -$23.85 | – |
| Q1 FY2019 | Mar 31, 2019 | -$57.30 | – |
| Q3 FY2018 | Sep 30, 2018 | -$37.05 | – |
| Q2 FY2018 | Jun 30, 2018 | -$114.90 | – |
| Q1 FY2018 | Mar 31, 2018 | -$810.00 | – |
| Q3 FY2017 | Sep 30, 2017 | -$4920.00 | – |
| Q2 FY2017 | Jun 30, 2017 | -$5475.00 | – |
| Q1 FY2017 | Mar 31, 2017 | -$21232.50 | – |
| Q3 FY2016 | Sep 30, 2016 | -$22312.50 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?